CORDIS
EU research results

CORDIS

English EN

AnThocyanin and polyphenol bioactives for Health Enhancement through Nutritional Advancement

Project information

Grant agreement ID: 245121

Status

Closed project

  • Start date

    1 July 2010

  • End date

    30 June 2015

Funded under:

FP7-KBBE

  • Overall budget:

    € 4 292 680,85

  • EU contribution

    € 2 996 226

Coordinated by:

JOHN INNES CENTRE

United Kingdom

Objective

Anthocyanins are health promoting dietary polyphenols that protect against cardiovascular disease, caner and obesity in preclinical studies with animals. The ATHENA project will address how good dietary anthocyanins are in protecting against chronic disease, by addressing the following questions: • Benefits and risks: What is the dose response to anthocyanin phytonutrients? Are anthocyanins from different food sources equivalent? How well do anthocyanins perform in promoting health compared to other polyphenol phytonutrients such as stilbenes, isoflavones and epicatechins? • Mechanisms of action: What are the mechanisms of action of polyphenol phytonutrients in combating chronic diseases? How do anthocyanins limit weight gain/fat development? How do dietary anthocyanins offer cardioprotection? How do dietary anthocyanins slow the progression of cancers? • Food or Pharma: Supplements or extracts of polyphenols do not appear to promote health as well as when they are consumed in whole foods. What is the influence of nutritional context on the efficacy of polyphenol phytonutrients? Does nutritional context influence the bioavailability of polyphenol phytonutrients? • Roles in human: Do dietary anthocyanins afford protection against cardiovascular disease, cancer and other chronic diseases in human? It is the uniqueness of the interactions that ATHENA will promote, that will innovate and give the most significant added-value to Europe. ATHENA will bring together groups with widely different expertise from across Europe, so that the consortium will be able to achieve significant progress towards addressing the Grand Challenge of Chronic Disease. It will impact the health, well being and quality of life across Europe.

Coordinator

JOHN INNES CENTRE

Address

Norwich Research Park Colney
Nr4 7uh Norwich

United Kingdom

Activity type

Research Organisations

EU Contribution

€ 388 840

Administrative Contact

Mary Anderson (Dr.)

Participants (12)

UNIVERSITE JOSEPH FOURIER GRENOBLE 1

France

UNIVERSITA DEGLI STUDI DI MILANO

Italy

EU Contribution

€ 509 000

LEIBNIZ - INSTITUT FUER PFLANZENGENETIK UND KULTURPFLANZENFORSCHUNG

Germany

EU Contribution

€ 264 001

UNIVERSITA CATTOLICA DEL SACRO CUORE

Italy

EU Contribution

€ 84 319,87

STICHTING WAGENINGEN RESEARCH

Netherlands

EU Contribution

€ 270 000

UNIVERSITE GRENOBLE ALPES

France

EU Contribution

€ 273 012

ISTANBUL TEKNIK UNIVERSITESI

Turkey

EU Contribution

€ 180 158

ISTITUTO EUROPEO DI ONCOLOGIA SRL

Italy

EU Contribution

€ 268 800

CONSIGLIO PER LA RICERCA IN AGRICOLTURA E L'ANALISI DELL'ECONOMIA AGRARIA

Italy

EU Contribution

€ 116 100

QUADRAM INSTITUTE BIOSCIENCE

United Kingdom

EU Contribution

€ 268 500

KOS GENETIC S.R.L.

Italy

EU Contribution

€ 157 815

INSTITUTO NEUROLOGICO MEDITERRANEO- NEUROMED SRL

Italy

EU Contribution

€ 215 680,13

Project information

Grant agreement ID: 245121

Status

Closed project

  • Start date

    1 July 2010

  • End date

    30 June 2015

Funded under:

FP7-KBBE

  • Overall budget:

    € 4 292 680,85

  • EU contribution

    € 2 996 226

Coordinated by:

JOHN INNES CENTRE

United Kingdom